Human technopole Milan

Highlights

Research at HT

Improving human health and well-being is the ultimate goal of Human Technopole. We need to prevent and cure diseases to allow people of all ages to not only live longer, but also live better.

Discover more about our:

Thanks to a comprehensive and interdisciplinary approach to the study of human biology, HT’s research aims to understand the mechanisms underlying various diseases, exploiting the technological advances of the last decade and the enormous amount of biological, clinical and socio-economic data currently available to improve the national healthcare system and the quality of life of all citizens.

Human Technopole’s research is based on five interdisciplinary research areas: Genomics, Neurogenomics, Structural Biology, Computational Biology and Health Data Science.

Starting from early 2024, Human Technopole will be opening the first National Facilities available to the national scientific community to carry out top-level research in their respective fields.

Courses and Conferences

The overarching and inspiring theme for HT’s external training activities is to create a centre of excellence for training promising researchers in the biomedical sciences, while enabling broad access to HT’s expertise, methods and resources.

Work with us

We offer the opportunity to be part of a new, dynamic research institute promoting a highly collaborative and international working environment.

We aim to attract the best resources in each field with a selection based on merit and transparency as we believe that highly diverse teams produce the best and most innovative results.

If you are a passionate person who likes to seize great challenges, consider applying for one of our scientific or administrative vacancies. 

Latest news

To keep up to date with Human Technopole’s development and the activities of the institute, sign up to our newsletter. The HT newsletter is sent every three months or so to share what is happening at HT: news, events, scientific and dissemination initiatives, job and training opportunities and much more.
  • Members of the CIVP appointed

    The Consiglio di Sorveglianza of the Human Technopole Foundation has appointed eight experts with proven professional qualifications to form the Standing Independent Evaluation Committee (CIVP).

    Read more
  • Two ERC-funded projects to search for tumours’ weaknesses

    Human Technopole has once again been awarded by Europe’s prestigious public body for funding of scientific research conducted within the European Union, the European Research Council (ERC), for two projects on the origin of tumours, their evolution and the development of resistance to therapies. The two studies could contribute to the identification of new anti-cancer targeted treatments.

    Read more
  • COVID-19: How SARS‑CoV‑2 Enters Human Cells

    A study by the University of Padua and Human Technopole, together with the University of Milan and the European Institute of Oncology, published in Cell Reports Medicine, reveals that SARS-CoV-2, the virus that causes COVID-19, binds the RAGE receptor present on the surface of specific human immune cells to penetrate them and pathologically alter their function. This study also shows how the involvement of RAGE, previously known only in the context of other pathophysiological conditions, such as obesity and diabetes, is implicated in the degree of severity with which COVID-19 can manifest.

    Read more
  • Italy joins the iCARE4CVD consortium

    The Human Technopole and Mario Negri institute for Pharmacological Research are among 33 leading international partners who have joined forces to better understand cardiovascular diseases and optimise future prevention and treatment.

    Read more
  • Study tour “Austrian Life Science Innovation Ecosystem” in Vienna

    The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems. From 28 to 30 November 2023, CITT is organising a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.

    Read more
  • Annotating human genes: where do we stand now?

    In a perspective article published in Nature, Piero Carninci and colleagues discuss the status of human gene annotation and how high-throughput RNA sequencing technologies have accelerated the discovery of non-coding RNA genes with unknown functions and will promote the completion of the human gene catalogue.

    Read more